SIRT1 and metabolic dysfunction-associated steatotic liver disease: In previous models, reduced SIRT1 expression has been associated with impaired reverse cholesterol transport [75], increased atherosclerotic risk [80], and susceptibility to gallstone formation [81], whereas enhanced SIRT1 activity exerts protective effects against non-alcoholic fatty liver disease (NAFLD) [82].